Actively Recruiting

Phase 4
Age: 18Years - 45Years
FEMALE
NCT04479072

Aspirin and Preeclampsia

Led by University of Chicago · Updated on 2026-05-04

180

Participants Needed

1

Research Sites

306 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This is a single-center, double-blind, randomized, placebo-controlled clinical trial. Peripartum and postpartum Activin A are significantly elevated in women with preeclampsia. Our hypothesis is that elevated Activin A levels reflect a remediable signal and that reducing postpartum Activin A levels with aspirin therapy will improve (GLS) in preeclamptic patients.

CONDITIONS

Official Title

Aspirin and Preeclampsia

Who Can Participate

Age: 18Years - 45Years
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Pregnant adults between 18 and 45 years of age
  • Diagnosed with preeclampsia
  • Presenting for delivery with a singleton pregnancy
Not Eligible

You will not qualify if you...

  • Patients in labor
  • History of cardiomyopathy, chronic hypertension, ischemic or valvular heart disease, pulmonary disease, diabetes mellitus, or chronic kidney disease
  • Multiple pregnancy (more than one fetus)
  • Planning to deliver outside the study site
  • Participation in other trials that might affect study medication use
  • Allergy to aspirin
  • Clear need for aspirin therapy or any contraindication to aspirin
  • Conditions that may limit following the study, such as peptic ulcers, gastrointestinal bleeding, or bleeding disorders
  • Currently using or planning to take nonsteroidal anti-inflammatory drugs during the study
  • Unable to provide informed consent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of Chicago Hospital

Chicago, Illinois, United States, 60637

Actively Recruiting

Loading map...

Research Team

S

Sajid Shahul, MD, PhD

CONTACT

C

Colleen Duncan, RN

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

FACTORIAL

Primary Purpose

PREVENTION

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here